Thomas Knittel

Biography

Dr. Thomas Knittel has been the Chief Medical Officer at Modus Therapeutics AB since August 2017. Dr. Knittel has been the Chief Medical Officer of InDex Pharmaceuticals AB and InDex Pharmaceuticals Holding AB (publ) since January 2012. He has over 15 years of clinical experience within gastroenterology as well as 13 years of experience in medical affairs and marketing management. Before joining Modus Therapeutics, he worked for Prima Biomed, Berlin as Executive Vice President of Medical & Scientific Development from 2016 to 2017. He served as Business Unit Director from 2010 to 2014 and Director of Sales and Marketing at Novo Nordisk Pharma GmbH for central Europe until 2010, as General Manager Pharmaceuticals at Harlan Laboratories until 2011 and as Vice President of Corporate and Medical Affairs at Develogen AG from 1999 to 2004. He served as the Chief Executive Officer of Gastrogenics UG until 2015 and Consultant for Medoderm GmbH until 2013. He serves as an Associate Professor in Internal Medicine and Gastroenterology at the University Clinic Goettingen. He has a Medical degree from the University of Mainz with a specialist training in internal medicine and gastroenterology. Dr. Knittel holds an MBA from Kellogg School of Management/WHU at Northwestern University, U.S. 

Research Interest

 Haematology